Citigroup Inc. - Net Worth and Insider Trading
Citigroup Inc. Net Worth
The estimated net worth of Citigroup Inc. is at least $261 Million dollars as of 2024-11-11. Citigroup Inc. is the of CanSino Biologics Inc and owns about 7,334,766 shares of CanSino Biologics Inc (HKSE:06185) stock worth over $261 Million. Details can be seen in Citigroup Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Citigroup Inc. has not made any transactions after 2023-02-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Citigroup Inc.
Citigroup Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Citigroup Inc. owns 1 companies in total, including CanSino Biologics Inc (HKSE:06185) .
Click here to see the complete history of Citigroup Inc.’s form 4 insider trades.
Insider Ownership Summary of Citigroup Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:06185 | CanSino Biologics Inc | 2023-02-17 |
Citigroup Inc. Latest Holdings Summary
Citigroup Inc. currently owns a total of 1 stock. Citigroup Inc. owns 7,334,766 shares of CanSino Biologics Inc (HKSE:06185) as of February 17, 2023, with a value of $261 Million.
Latest Holdings of Citigroup Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:06185 | CanSino Biologics Inc | 2023-02-17 | 7,334,766 | 35.65 | 261,484,408 |
Holding Weightings of Citigroup Inc.
Citigroup Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Citigroup Inc. has made a total of 118 transactions in CanSino Biologics Inc (HKSE:06185) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in CanSino Biologics Inc is the sale of 0 shares on February 17, 2023, which brought Citigroup Inc. around $0.
Insider Trading History of Citigroup Inc.
- 1
Citigroup Inc. Trading Performance
Citigroup Inc. Ownership Network
Ownership Network List of Citigroup Inc.
Ownership Network Relation of Citigroup Inc.
Citigroup Inc. Owned Company Details
What does CanSino Biologics Inc do?
Who are the key executives at CanSino Biologics Inc?
Citigroup Inc. is the of CanSino Biologics Inc. Other key executives at CanSino Biologics Inc include 2201 Interest of corporation controlled by you The Capital Group Companies, Inc. , Jpmorgan Chase & Co. , and 2201 Interest of corporation controlled by you The Goldman Sachs Group, Inc. .
CanSino Biologics Inc (HKSE:06185) Insider Trades Summary
Over the past 18 months, Citigroup Inc. made no insider transaction in CanSino Biologics Inc (HKSE:06185). Other recent insider transactions involving CanSino Biologics Inc (HKSE:06185) include a net purchase of 360,400 shares made by Jpmorgan Chase & Co. , and a net sale of 6,747,000 shares made by The Capital Group Companies, Inc. .
In summary, during the past 3 months, insiders sold 0 shares of CanSino Biologics Inc (HKSE:06185) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,168,200 shares of CanSino Biologics Inc (HKSE:06185) were sold and 781,600 shares were bought by its insiders, resulting in a net sale of 6,386,600 shares.
CanSino Biologics Inc (HKSE:06185)'s detailed insider trading history can be found in Insider Trading Tracker table.
CanSino Biologics Inc Insider Transactions
Citigroup Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Citigroup Inc.. Currently GuruFocus does not have mailing address information for Citigroup Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
